Atea Pharmaceuticals Inc (AVIR)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] by (Cboe BZX)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] [[ item.lastPriceExt ]] [[ item.priceChangeExt ]] ([[ item.percentChangeExt ]]) [[ item.tradeTimeExt ]]
Fiscal Year End Date: 12/31
| 06-2024 | 03-2024 | 12-2023 | 09-2023 | 06-2023 | |
| Cash Flows From Operating Activities | |||||
| Net Income | -103,691 | -63,169 | -135,956 | -96,792 | -63,650 |
| Depreciation Amortization | -6,304 | -3,384 | -15,030 | -10,789 | -6,576 |
| Accounts payable and accrued liabilities | 1,218 | 16,885 | 1,701 | -2,156 | 1,411 |
| Other Working Capital | 2,622 | 14,102 | 16,163 | 6,749 | -632 |
| Other Operating Activity | 24,088 | -4,299 | 47,727 | 39,427 | 23,477 |
| Operating Cash Flow | $-82,067 | $-39,865 | $-85,395 | $-63,561 | $-45,970 |
| Cash Flows From Investing Activities | |||||
| Change In Deposits | 355,948 | 56,802 | 40,303 | 12,532 | 71,045 |
| PPE Investments | -174,460 | N/A | N/A | N/A | N/A |
| Investing Cash Flow | $181,488 | $56,802 | $40,303 | $12,532 | $71,045 |
| Cash Flows From Financing Activities | |||||
| Common Stock Issued | 150 | 150 | 257 | 257 | 165 |
| Financing Cash Flow | $150 | $150 | $257 | $257 | $165 |
| Beginning Cash Position | 143,823 | 143,823 | 188,658 | 188,658 | 188,658 |
| End Cash Position | 243,394 | 160,910 | 143,823 | 137,886 | 213,898 |
| Net Cash Flow | $99,571 | $17,087 | $-44,835 | $-50,772 | $25,240 |
| Free Cash Flow | |||||
| Operating Cash Flow | -82,067 | -39,865 | -85,395 | -63,561 | -45,970 |
| Capital Expenditure | -174,460 | N/A | N/A | N/A | N/A |
| Free Cash Flow | -256,527 | -39,865 | -85,395 | -63,561 | -45,970 |